Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Department of Gynecology, Division of Gynecology and Reproduction, Karolinska University Hospital, Stockholm, Sweden.
Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden; Department of Psychology, Umeå University, Umeå, Sweden.
Gynecol Oncol. 2024 Oct;189:101-108. doi: 10.1016/j.ygyno.2024.07.004. Epub 2024 Jul 30.
This study aimed to investigate health-related quality of life (HRQoL), sexual function, psychological-health, reproductive concerns, and fertility outcomes of women of reproductive age undergoing Fertility-Sparing Surgery (FSS) for treatment of ovarian cancer (OC) or borderline ovarian tumor (BOT), over a 2-year period.
Prospective longitudinal multicentre study including women 18-40 years undergoing FSS between 2016 and 2018 in Sweden. Clinical data at diagnosis, histopathological findings and 2-year follow-up regarding oncological and reproductive outcomes were collected. Participants completed the EORTC QLQ-C30 and OV-28, FSFI, HADS and study-specific items at time of diagnosis and at one- and two-years following FSS. Data were analysed using a model for repeated measures to investigate changes over time.
Of 68 eligible women, 49 were included following exclusions due to benign pathology or subsequent radical surgery. During a mean follow-up of 20.5 months, two women experienced a recurrence and 82% reported regular menstruations. The majority (94%) had a strong desire to become biological mothers, which remained or increased over time. The conception-rate was 76%. HRQoL, psychological-health and sexual function improved over time and the proportion of women with sexual dysfunction decreased. At one-year follow-up 50% of nulliparous women had scores indicating sexual dysfunction compared to 0% of the women who had given birth either before or after surgery (p = 0.008).
HRQoL, psychological-health and sexual function improved during two-year follow-up after FSS in young women presenting with OC or BOT. Women who had given birth prior to or after FSS reported improved sexual function compared to nulliparous women.
本研究旨在调查接受保留生育功能手术(FSS)治疗卵巢癌(OC)或交界性卵巢肿瘤(BOT)的育龄妇女在 2 年内的健康相关生活质量(HRQoL)、性功能、心理健康、生殖问题和生育结局。
这是一项前瞻性纵向多中心研究,纳入了 2016 年至 2018 年期间在瑞典接受 FSS 的 18-40 岁女性。收集了诊断时的临床数据、组织病理学发现以及 2 年随访时的肿瘤学和生殖结局。参与者在诊断时以及 FSS 后 1 年和 2 年时完成了 EORTC QLQ-C30 和 OV-28、FSFI、HADS 和研究特定项目。使用重复测量模型分析数据,以调查随时间的变化。
在 68 名符合条件的女性中,有 49 名因良性病理或随后的根治性手术而被排除在外。在平均 20.5 个月的随访期间,有 2 名女性复发,82%的女性报告有规律的月经。大多数(94%)强烈希望成为生物学母亲,这种愿望随着时间的推移保持或增加。妊娠率为 76%。HRQoL、心理健康和性功能随时间改善,性功能障碍的女性比例下降。在 1 年随访时,50%的未生育女性的性功能评分表明存在性功能障碍,而在手术前或手术后生育的女性中,这一比例为 0%(p=0.008)。
在接受 FSS 治疗 OC 或 BOT 的年轻女性中,在 2 年随访期间,HRQoL、心理健康和性功能得到改善。与未生育的女性相比,接受 FSS 前或后生育的女性报告性功能得到改善。